The
International Society for Dendritic Cell & Vaccine Science is a
non-profit, web-based organization to promote cross-disciplinary
approaches in designing new vaccines that harness the elaborate
properties of dendritic cells in controlling immunity in infectious
diseases, cancer, allergy, and chronic inflammation. Read more
Not yet a member?
Join DC-Vaccine today and help make a difference in vaccine science!
Benefits
- Get 10% discount on vaccine meetings
- Research literature digest by leading labs in the field
- Members-only discussion forum
- Job opportunities board
- Easy communication with colleagues
$50/year regular
$25/person for lab/department membership (5 person minimum)
$25/year for all students and those in Discount Countries
FREE to those in Selected Countries
$500 lifetime membership offered through 30 April 2011
$1000 Awards for the
Best Literature Reviews in 2011
Read more
Research Highlights
- A potential future sphere for vaccination would be to learn to induce T cells that suppress immunity. Read more
- To improve vaccination with proteins, Klechevsky E. et al. evaluated human CD8+ T cell responses in culture after antigen targeting to dendritic cells (DCs) through different lectins, with emphasis on the ITIM containing DC immunoreceptor (DCIR). Read more
- CD8+ T cell responses to vaccines can be improved throughcross-presentation. Read more
- Synthetic double stranded RNA, such as poly ICLC, are being considered as adjuvants for vaccines. Read more
How You Can Help
Your
gift will make a difference in the field of vaccine science. Every
dollar you donate to DC-Vaccine goes toward bridging dendritic cell and
vaccine science, and to funding travel of young scientists to meetings in these fields.
